PHL Announces Distribution of Orasure Products

Pasante Healthcare, a leading provider of sexual health and wellness products, today announced a new distribution agreement aimed at expanding access to innovative self-testing solutions across the United Kingdom.

Under the agreement, Pasante Healthcare will distribute OraSure Technology Inc.’s portfolio of HIV and HCV rapid diagnostic products through its established healthcare channels. The collaboration is intended to increase availability of convenient, reliable testing options and support broader public health initiatives focused on early detection and access to care.

Pasante Healthcare's extensive market presence and relationships across healthcare and public health organisations are expected to accelerate the adoption and availability of OraSure's diagnostic solutions.

"Partnering with OraSure enables us to broaden the range of innovative testing solutions available to our customers and healthcare partners," said Kevin Mearns, Managing Director at Pasante Healthcare. "Together, we aim to enhance access to high-quality self-testing products that support informed health decisions and improved health outcomes."

The companies expect the agreement to strengthen access to diagnostic testing while supporting public health efforts focused on prevention, awareness, and earlier intervention.

About Pasante Healthcare

Pasante Healthcare is a leading supplier of sexual health, wellness, and diagnostic products, working with healthcare professionals, pharmacies, retailers, and public health organisations throughout the UK and internationally.